GlassScriptPhysician profile
Gloria Cheng
NPI 1548662109
$3,738.56
in general payments reported to CMS, 2019-2025
22 companies · $1,228 in 2025
The $1,228 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $119 · 2022: $542 · 2023: $1,180 · 2024: $670 · 2025: $1,228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,077.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,077.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $482.22 | 2022-2025 | Zepbound, Omvoh, Mounjaro |
| Abbvie INC. | $384.26 | 2022-2024 | |
| Dexcom, INC. | $350.66 | 2023-2025 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Galderma Laboratories, L.P. | $271.72 | 2025 | Nemluvio |
| Gilead Sciences, INC. | $226.21 | 2023-2025 | Yeztugo, Epclusa |
| Dermavant Sciences, INC. | $195.31 | 2023 | Vtama |
| Genzyme Corporation | $179.12 | 2023-2024 | |
| Medtronic, INC. | $176.52 | 2023 | Onyx Frontier |
| Organon LLC | $167.86 | 2025 | Vtama |
| Leo Pharma INC. | $137.30 | 2025 | Adbry |
| Teva Pharmaceuticals USA, INC. | $132.12 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $130.64 | 2023 | Lifevest |
| Madrigal Pharmaceuticals | $129.87 | 2025 | Rezdiffra |
| Glaxosmithkline, LLC. | $118.74 | 2021 | |
| Amylyx Pharmaceuticals, INC. | $114.27 | 2023 | Relyvrio |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $107.90 | 2022-2024 | |
| Eisai INC. | $105.90 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $104.00 | 2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $95.59 | 2022 | |
| Neurocrine Biosciences, INC. | $62.63 | 2024 | Ingrezza |
| Myriad Genetic Laboratories, INC. | $42.75 | 2023 | Precisetumor |
| Exact Sciences Corporation | $22.97 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gloria Cheng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.